Neuro oncology News and Research

RSS
Experts call for more research into treatments for children's brain tumours

Experts call for more research into treatments for children's brain tumours

Research offers new molecular approaches to therapies for the most deadly cancers

Research offers new molecular approaches to therapies for the most deadly cancers

Promising new molecular targets and treatment approaches for some of the most malignant brain tumors

Promising new molecular targets and treatment approaches for some of the most malignant brain tumors

Oncolytic viruses may one day help treat brain tumors

Oncolytic viruses may one day help treat brain tumors

Approval for Temodar (temozolomide) capsules for newly diagnosed glioblastoma multiforme

Approval for Temodar (temozolomide) capsules for newly diagnosed glioblastoma multiforme

New chemotherapy gives hope to brain tumour patients

New chemotherapy gives hope to brain tumour patients

Researchers turn fatal brain cancer into treatable disease for children

Researchers turn fatal brain cancer into treatable disease for children

Immunotherapy and chemotherapy combined, slows tumor progression and extends survival of patients with glioblastoma multiforme

Immunotherapy and chemotherapy combined, slows tumor progression and extends survival of patients with glioblastoma multiforme

Physicians offer several promising and unique approaches to brain tumor treatment

Physicians offer several promising and unique approaches to brain tumor treatment

Cognitive decline can occur before chemotherapy treatment

Cognitive decline can occur before chemotherapy treatment

World's first gene therapy trial aimed at preventing cancer

World's first gene therapy trial aimed at preventing cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.